Yüklüyor......
IL-10 and PD-1 cooperate to limit the activity of tumor-specific CD8(+) T cells
Immune checkpoint inhibitors show great promise as therapy for advanced melanoma, heightening the need to determine the most effective use of these agents. Here, we report that programmed death-1(high) (PD-1(high)) tumor antigen (TA)-specific CD8(+) T cells present at periphery and at tumor sites in...
Kaydedildi:
| Yayımlandı: | Cancer Res |
|---|---|
| Asıl Yazarlar: | , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4401638/ https://ncbi.nlm.nih.gov/pubmed/25720800 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-14-3016 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|